August 2017 - Volume 23 - Issue 8 - Contributor Index

Author:
Olivares, David

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.